Cleared Traditional

K221467 - INHANCETM Reverse Glenoid Peripheral Posts

K221467 is the FDA 510(k) clearance for INHANCETM Reverse Glenoid Peripheral Posts by Depuy Ireland UC. It is a Class 2 Orthopedic device (product code PHX) cleared through the Traditional 510(k) pathway after a 103-day FDA review.

K221467 · Depuy Ireland UC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
103d
Days
Class 2
Risk

K221467 is an FDA 510(k) clearance for the INHANCETM Reverse Glenoid Peripheral Posts. Classified as Shoulder Prosthesis, Reverse Configuration (product code PHX), Class II - Special Controls.

Submitted by Depuy Ireland UC (Ringaskiddy, IE). The FDA issued a Cleared decision on August 31, 2022 after a review of 103 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3660 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Depuy Ireland UC devices

Submission Details

510(k) Number K221467 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2022
Decision Date August 31, 2022
Days to Decision 103 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 122d · This submission: 103d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PHX Shoulder Prosthesis, Reverse Configuration
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3660
Definition Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Ignite Orthopedics, LLC
Russ Parrott

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PHX Shoulder Prosthesis, Reverse Configuration

All 178
Devices cleared under the same product code (PHX) and FDA review panel - the closest regulatory comparables to K221467.
Glenoid Reconstruction System
K213459 · Medacta International S.A. · Nov 2022
Humeris® 135 Shoulder System
K222936 · Fx Shoulder USA, Inc. · Nov 2022
Tornier Perform Humeral System – Fracture
K220914 · Tornier, Inc. · Oct 2022
Catalyst R1 Reverse Shoulder System
K213349 · Catalyst Orthoscience, Inc. · Jun 2022
FX V135 Shoulder Prosthesis
K213117 · Fx Shoulder USA, Inc. · Jun 2022
INHANCE™ Reverse Shoulder System
K212737 · Depuy Ireland UC · Apr 2022